The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy. - Wikidata - awgldk - TriplyDB

The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy.

The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy.

http://www.wikidata.org/entity/Q40294402

about

Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights.Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.Oxazolone-induced contact hypersensitivity reduces lymphatic drainage but enhances the induction of adaptive immunity.Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.Immunomodulation of malignant melanoma by contact sensitizing agents.Epicutaneous Immunotherapy for Aeroallergen and Food Allergy.Is The Allergen Really Needed in Allergy Immunotherapy?Cutaneous vaccination with coated microneedles prevents development of airway allergy.Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model.

P2860

Q27004702-5212D29F-7D10-44AC-B772-0A83B7520711 Q34195289-228E519A-BBCC-4619-A141-828140EE8819 Q34402672-9177B170-CDDF-470F-8B33-C1A69F3B499C Q35184089-91FE65D0-F9D0-4829-BC53-F6A6B1067BD7 Q36302500-F855794F-9C46-4396-A870-E59EB262F559 Q38168949-7F277706-CA40-4D86-8621-B5BDD7EF9969 Q42578489-DF739E68-D372-40C6-8DCF-5FBACB3D6712 Q42730811-03532747-79E2-4C69-B28F-38DF5038DB5F Q47778162-2ACCE3A1-9E47-4112-83BC-95CC88229165 Q51767255-7D57D5C4-8A4F-4AFB-903A-B6C3B1B61469

P2860

The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy.

http://www.wikidata.org/entity/Q40294402

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The contact sensitizer dipheny ...... in epicutaneous immunotherapy.

@en

type

label

The contact sensitizer dipheny ...... in epicutaneous immunotherapy.

@en

prefLabel

The contact sensitizer dipheny ...... in epicutaneous immunotherapy.

@en

P1433

Q40294402-A20FAFFC-5D70-4066-915B-DC32E39044CA

P1476

Q40294402-AFBCA61D-D026-4B4A-81D7-EB04510433F8

P2093

Q40294402-0CDEB46D-1C8C-4EB7-9ADD-AC25B6222215

Q40294402-34E7420C-A1FC-48E9-B307-AF1B1B299335

Q40294402-5DD39DA7-FA03-48BA-8482-A855745177B6

Q40294402-6A34A930-9DC3-4EDA-876F-94D912DCA182

Q40294402-932C18A4-22D4-4EC0-B8AC-A7DA0E337A46

Q40294402-AE965855-B0B1-409A-9F35-7B033AC0B15E

Q40294402-D8B5284D-C826-4A50-AAF0-C00FB473E75E

P2860

Q40294402-059F3FF0-D720-4E58-B745-873626830E49

Q40294402-0EDA3416-F5AE-48DC-816F-0619A9366289

Q40294402-172689FE-4EC5-4B98-AA91-ED9E99FCB399

Q40294402-333874B4-E8F1-4D85-B178-590359944AC7

Q40294402-3CFD1644-8882-4ECA-B5B9-3DD3495A1A15

Q40294402-434E2D5F-3A50-4F86-9B78-899F4319AA6C

Q40294402-44776251-0249-4AE0-BC0D-49829DEC0994

Q40294402-4E6E4A72-CB5A-4231-98A1-DFFB2AAD80F3

Q40294402-5B695E39-66BA-406A-8B28-26E46423EBCE

Q40294402-629F6AC3-964B-41C1-8109-97BF4A918F52

P304

Q40294402-11023AEB-D0C6-45C0-A598-C31F6910B4F1

P31

Q40294402-22472929-BEE3-4837-A0E8-1222D79C658F

P356

Q40294402-34F1397B-B4CF-4107-AD4B-E5C5D7B02EB0

P433

Q40294402-1B294FE4-945D-4318-A812-92E7ED3E900D

P478

Q40294402-CB4EF167-285C-4C0D-B2CA-77FC8C3CB25A

P577

Q40294402-7EF672E9-0E68-4F1F-97B9-BF78A8A8931A

P5875

Q40294402-D932BFED-90B3-4049-BBE1-1B6AF28BA91B

P698

Q40294402-8B527AE4-8A0E-4CEA-9068-BE1BA67C6E0F

P356

J.1398-9995.2012.02802.X

P1433

P1476

The contact sensitizer dipheny ...... in epicutaneous immunotherapy.

@en

P2093

A Häffner

http://www.w3.org/2001/XMLSchema#string

D Mohanan

http://www.w3.org/2001/XMLSchema#string

G Senti

http://www.w3.org/2001/XMLSchema#string

P Johansen

http://www.w3.org/2001/XMLSchema#string

S von Moos

http://www.w3.org/2001/XMLSchema#string

T M Kündig

http://www.w3.org/2001/XMLSchema#string

Y Waeckerle-Men

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of chemical-induced innate immunity in allergic contact dermatitis.

Immunological mechanisms of allergen-specific immunotherapy

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice

Fcgamma receptors: old friends and new family members

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants.

Dissolving polymer microneedle patches for influenza vaccination.

The therapeutic use of topical contact sensitizers in benign dermatoses.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.

P304

638-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1398-9995.2012.02802.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221879678

http://www.w3.org/2001/XMLSchema#string

P698

22380933

http://www.w3.org/2001/XMLSchema#string